Cite

HARVARD Citation

    Hedvat, M. et al. (n.d.). 697 Tumor-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors. Journal for immunotherapy of cancer. p. A739. [Online]. 
  
Back to record